PMS2 and Lynch syndrome: Different methodologies, such as single-marker versus multi-marker MSI panels and varied IHC protocols, can affect the detection rates of Lynch syndrome, especially for subtler MSH6 and PMS2 mutations known for their heterogeneous expression.